Newsletter | May 1, 2025

Best of April: Top 5 Insights In Drug Formulation & Delivery

Drug Delivery Leader

TOP 5 INSIGHTS IN DRUG FORMULATION AND DELIVERY 

APRIL EDITION

#1 - Design Controls For Drug Delivery Devices, Part 1: A Process Primer

In this article, Fran DeGrazio underscores the importance of design controls in the development of combination products and other drug delivery devices. She explains foundational concepts and fundamental steps including design inputs and outputs, design verification and validation, design review, and change controls.

#2 - Enabling Subcutaneous Delivery For Improved Patient Compliance And Healthcare System Efficiencies

The ability to administer high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens.

#3 - The Technologies Propelling GLP-1 Analogues

The global GLP-1 analogues market is projected to reach USD 471.10 billion by 2032 from USD 47.49 billion In 2024. This article delves into the manufacturing and synthesizing technologies used to manufacture GLP-1 drugs as well as the novel drug delivery technologies being used.

#4 - 3D Screen Printing: Enabling A New Generation Of Complex Formulations

Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients and enabling near-endless possibilities for geometric shaping of dosage forms.

#5 - Oral Therapies Take Center Stage For PsO And PsA Treatment

The recent American Academy of Dermatology 2025 Annual Meeting in early March saw major updates for two key oral therapies in autoimmune diseases.The drugs reported promising efficacy in moderate-to-severe psoriasis (PsO) and psoriatic arthritis (PsA).